Previous studies have found that the up-regulation of BGN in a variety of solid tumors (19–21) and its potential diagnostic and prognostic value in ovarian cancer (21), prostate cancer (22), gastric cancer (23) and colorectal cancer (24, 25). This evidence concerns the gene BGN and colorectal cancer.